clinical trial · NCT04388501
A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants
Janssen Pharmaceutica N.V., Belgium·phase1·completed·n = 23
HealthyMilvexianAtorvastatin
brief summary
The purpose of this study is to evaluate the potential pharmacokinetics (PK) interaction between milvexian and atorvastatin (and its metabolites) in healthy participants at steady state.
started
Jun 7, 2021
primary completion
Oct 25, 2021
completion
Oct 27, 2021
last updated
Mar 30, 2025
official title
A Single-center, Open-label, Randomized, Three-way Cross-over Study Evaluating Drug Drug Interaction Between JNJ-70033093 and Atorvastatin in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol